From biotech financing to new drugs, from single-cell biology to advanced models for drug discovery: what were the most-...
A New Hope for Alzheimer’s Patients: Donanemab and Its Impact on Disease Progression
Alzheimer’s disease remains one of the most challenging neurodegenerative disorders to treat, with its progressive cog...
Amyloid Is Everywhere, but New Treatments Could Stop the Toxic Build Up
Amyloid deposits are not only present in the brains of cognitively impaired individuals but also accumulate throughout t...
Innovating Protease Inhibition: Advancing Targeted Therapies for Disease Treatment
Protease inhibition faces challenges due to specificity and safety concerns. Innovative approaches, including non-natura...
ReChb: An Ancestral CRISPR–Cas12a variant with flexible applications
Ancestral sequence reconstruction has led to the discovery and synthesis of ReChb, a revolutionary variant of CRISPR–C...
Gut Revolution: Fecal Transplants vs. Live Biotherapeutic Products
An article published in Gut Microbes (2024) introduces a groundbreaking class of drugs known as Live Biotherapeutic Prod...